Investigational Drug Information for PRX-03140
✉ Email this page to a colleague
What is the drug development status for PRX-03140?
PRX-03140 is an investigational drug.
There have been 4 clinical trials for PRX-03140.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2008.
The most common disease conditions in clinical trials are Alzheimer Disease, Stress Disorders, Traumatic, and Stress Disorders, Post-Traumatic. The leading clinical trial sponsors are Epix Pharmaceuticals, Inc., Ology Bioservices, and Nanotherapeutics, Inc.
Summary for PRX-03140
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2008-04-01) |
| Vendors | 4 |
Recent Clinical Trials for PRX-03140
| Title | Sponsor | Phase |
|---|---|---|
| Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder | Nanotherapeutics, Inc. | N/A |
| Pilot Study of PRX-03140 to Assess Safety for Use in Adult Subjects With Post Traumatic Stress Disorder | Ology Bioservices | N/A |
| Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease | Epix Pharmaceuticals, Inc. | Phase 2 |
Clinical Trial Summary for PRX-03140
Top disease conditions for PRX-03140
Top clinical trial sponsors for PRX-03140
US Patents for PRX-03140
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
